首页 | 本学科首页   官方微博 | 高级检索  
     

良、恶性胸腔积液联检Survivin、HnRNP、TUM2-PK、CK19mRNA的价值探讨
引用本文:曹卓,王良兴. 良、恶性胸腔积液联检Survivin、HnRNP、TUM2-PK、CK19mRNA的价值探讨[J]. 放射免疫学杂志, 2010, 23(1): 9-11
作者姓名:曹卓  王良兴
作者单位:温州医学院第六医院呼吸内科,323000;温州医学院附属第一医院呼吸内科,325300
摘    要:目的:通过检测不同性质胸腔积液中Survivin、HnRNP、TUM2-PK、CK19mRNA的表达,探讨它们在胸腔积液性质鉴别诊断中的价值。方法:选取60名胸腔积液患者,抽取胸腔积液后分别进行Survivin、HnRNP、TUM2-PK、CK19mRNA检测。采用ELISA。结果:Survivin、HnRNP、TUM2-PK、CK19mRNA在恶性胸腔积液中的检测结果明显高于良性胸腔积液中结果,差异有显著意义(P〈0.05)。结论:恶性胸腔积液中的Survivin、HnRNP、TUM2-PK、CK19mRNA的水平明显高于良性胸腔积液中的表达,差异有显著意义。联检Survivin+HnRNP、Survivin+TUM2-PK有较理想的敏感性和特异性。四项联检虽然敏感性有提高,但特异性下降明显,可能会影响实际应用。

关 键 词:胸腔积液  生存素基因、核糖核蛋白、肿瘤M2型丙酮酸激酶、CK19mRNA鉴别诊断  联检

Study on the Diagnostic Value of Combined Detection of Survivin, HnRNP, TUM2-PK and CK19mRNA in Pleural Effusion in Patients with Benign and Malignant Chest Disoders
Cao Zhuo. Study on the Diagnostic Value of Combined Detection of Survivin, HnRNP, TUM2-PK and CK19mRNA in Pleural Effusion in Patients with Benign and Malignant Chest Disoders[J]. Journal of Radioimmanology, 2010, 23(1): 9-11
Authors:Cao Zhuo
Affiliation:323000;325300
Abstract:Objective To study the differential diagnostic value of combined determination of pleural effusion contents of survivin,HnRNP,TUM2-PK and CK19mRNA in Patients with chest disorders.Methods Contents of survivin,heterogenous nuclear ribo-nucleo protein(HnRNA),TUM2-pyruvate kinase K(TUM2-PK) and CK19mRNA in plearal effusion were determined with ELISA in 30 patients with lung cancer and 30 patients with tuberculosis.Results Contents of all the four tumor markers in pleural effusion of patients with lung cancer w...
Keywords:pleural effusion  Survivin  HnRNP  TUM2-PK  CK19mRNA  differential diagnosis  combined examination  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号